<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2020-2382</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-2382</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>HEART FAILURE</subject></subj-group></article-categories><title-group><article-title>Анализ связи системного воспаления и диастолической дисфункции у пациентов с хронической сердечной недостаточностью на фоне ревматоидного артрита</article-title><trans-title-group xml:lang="en"><trans-title>Analysis of the relationship between systemic inflammation and diastolic dysfunction in patients with heart failure and rheumatoid arthritis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5188-7997</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Анкудинов</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Ankudinov</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Анкудинов Андрей Сергеевич — кандидат медицинских наук, доцент кафедры симуляционных технологий и экстренной медицинской помощи</p><p>Иркутск </p></bio><bio xml:lang="en"/><email xlink:type="simple">andruhin.box@ya.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2708-3972</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Калягин</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kalyagin</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Калягин Алексей Николаевич — доктор медицинских наук, профессор, заведующий кафедрой пропедевтики внутренних болезней</p><p>Иркутск </p></bio><bio xml:lang="en"/><email xlink:type="simple">akalagin@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО “Иркутский государственный медицинский университет” Минздрава России</institution></aff><aff xml:lang="en"><institution>Irkutsk State Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>01</day><month>05</month><year>2020</year></pub-date><volume>19</volume><issue>3</issue><fpage>2382</fpage><lpage>2382</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Анкудинов А.С., Калягин А.Н., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Анкудинов А.С., Калягин А.Н.</copyright-holder><copyright-holder xml:lang="en">Ankudinov A.S., Kalyagin A.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/2382">https://cardiovascular.elpub.ru/jour/article/view/2382</self-uri><abstract><sec><title>Цель</title><p>Цель. Изучить наличие и  характер взаимосвязи параметров системного воспалительного процесса с  морфофункциональными параметрами миокарда у пациентов, страдающих хронической сердечной недостаточностью (ХСН), как результат гипертонической болезни и ишемической болезни сердца, ассоциированной с ревматоидным артритом (РА).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В исследовании приняло участие 57 пациентов (женщин), страдающих ХСН, функциональный класс I-II по NYHA (New-York Heart Association). Пациенты разделены на две сопоставимые группы: 31 пациент, имеющих ХСН на фоне серопозитивного РА, рентгенологическая стадия I-III, и  26 пациентов с  ХСН без РА.</p></sec><sec><title>Результаты</title><p>Результаты. Сравнительный анализ морфофункциональных параметров не выявил значимых различий: уровень фракции выброса левого желудочка в группе ХСН и РА и группе ХСН без РА составил 51,06±5,6% и  51,6±6,4%, соответственно (р=0,7); соотношение максимальных скоростей в фазы раннего и позднего диастолического наполнения (Е/А) составило 0,9±0,1 и 0,8±0,1, соответственно (р=0,7). По другим эхокардиографическим параметрам различий также не выявлено (p&gt;0,05). При анализе взаимосвязи между выраженностью воспаления и морфофункциональными параметрами миокарда у пациентов группы ХСН и РА построена статистически значимая регрессионная модель между индексом активности (DAS28) РА, ревматоидным фактором и E/A: R=0,5; R2 =0,3; F=2,6; p=0,04.</p></sec><sec><title> Заключение</title><p> Заключение. В  результате проведенного исследования в  группе пациентов с  ХСН на  фоне РА выявлены умеренные статистически значимые прямые взаимосвязи индекса активности (DAS28) и  РА с одним из параметров оценки диастолической дисфункции левого желудочка — соотношением параметров трансмитрального потока (Е/А). Полученные данные могут указывать на неблагоприятный прогноз ХСН при нарастании активности РА.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To study the relationship of the systemic inflammation with the morphological and functional myocardial parameters in patients with heart failure (HF) due to hypertension and coronary artery disease in combination with rheumatoid arthritis (RA).</p></sec><sec><title>Material and methods</title><p>Material and methods. The study included 57 women with NYHA class I-II HF. Patients were divided into two comparable groups: group 1 (n=31) — patients with HF and seropositive RA (Steinbrocker X-ray stage I-III); group 2 (n=26) — HF patients without RA.</p></sec><sec><title>Results</title><p>Results. A comparative analysis of morphological and functional parameters did not reveal significant differences: left ventricular ejection fraction in groups 1 and 2 were 51,06±5,6% and 51,6±6,4%, respectively (p=0,7); the ratio of peak velocity blood flow in early diastole to peak velocity flow in late diastole (E/A) was 0,9±0,1 and 0,8±0,1, respectively (p=0,7). For other echocardiographic parameters, differences were also not detected (p&gt;0,05). Nevertheless, significant regression model was created between the RA activity score (DAS28), rheumatoid factor, and E/A was created: R=0,5; R2 =0,3; F=2,6; p=0,04.</p></sec><sec><title>Conclusion</title><p>Conclusion. As a result of the study, significant direct moderate correlation of the RA activity score (DAS28) with E/A ratio was revealed in the group of patients with HF and RA. The data obtained may indicate an unfavorable prognosis of HF with an increase in RA activity.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническая сердечная недостаточность</kwd><kwd>ревматоидный артрит</kwd><kwd>системное воспаление</kwd><kwd>коморбидность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>heart failure</kwd><kwd>rheumatoid arthritis</kwd><kwd>systemic inflammation</kwd><kwd>comorbidity</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Dickson VV, Buck H, Riegel B. A qualitative meta-analysis of heart failure self-care practices among individuals with multiple comorbid conditions. J Cardiac Fail. 2011;17(5):413-9. doi:10.1016/j.cardfail.2010.11.011.</mixed-citation><mixed-citation xml:lang="en">Dickson VV, Buck H, Riegel B. A qualitative meta-analysis of heart failure self-care practices among individuals with multiple comorbid conditions. J Cardiac Fail. 2011;17(5):413-9. doi:10.1016/j.cardfail.2010.11.011.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Серов В. А., Шутов А. М., Мензоров М.В. и др. Эпидемиология хронической болезни почек у больных с хронической сердечной недостаточностью. Нефрология. 2010;1(14):50-5. doi:10.24884/1561-6274-2010-14-1-50-55.</mixed-citation><mixed-citation xml:lang="en">Serov VA, Shutov AM, Menzorov MV, et al. Epidemiology of chronic kidney disease in patients with chronic heart failure. Nephrologiya. 2010;1(14):50-5. (In Russ.) doi:10.24884/1561-6274-2010-14-1-50-55.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Стронгин Л.Г., Починка И.Г., Конышева М.С., Морозова Е.П. Гликемический контроль и течение хронической сердечной недостаточности у больных сахарным диабетом 2 типа. Сахарный Диабет. 2012;2:17-21. doi:10.14341/2072-0351-5513.</mixed-citation><mixed-citation xml:lang="en">Strongin LG, Pochinka IG, Konysheva MS, Morozova EP. Glycemic control and the course of chronic heart failure in patients with type 2 diabetes. Sakharnyy Diabet. 2012;2:17- 21. (In Russ.) doi:10.14341/2072-0351-5513.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Калюта Т. Ю., Шварц Ю. Г., Соколов И. М. Сочетание ишемической болезни сердца и хронической сердечной недостаточности синдромом: особенности течения, влияние коррекции анемии на прогноз. Российский кардиологический журнал. 2013;(2):105-11. doi:10.15829/1560-4071-2013-2.</mixed-citation><mixed-citation xml:lang="en">Kalyuta TYu, Schwartz YuG, Sokolov IM. The combination of coronary heart disease and chronic heart failure with anemic syndrome: features of the course, the effect of the correction of anemia on the prognosis. Russian Journal of Cardiology. 2013;(2):105-11. (In Russ.) doi:10.15829/1560-4071-2013-2.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">McManus DD, Hsu G, Sung SH, et al. Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Ass. 2013;(1): e005694. doi:10.1161/JAHA.112.005694.</mixed-citation><mixed-citation xml:lang="en">McManus DD, Hsu G, Sung SH, et al. Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Ass. 2013;(1): e005694. doi:10.1161/JAHA.112.005694.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Анкудинов А. С., Калягин А.Н. Анализ взаимосвязи иммунологических факторов и воспалительных маркеров с течением хронической сердечной недостаточности на фоне ревматоидного артрита. Кардиология. 2018;58(10S):4-8. doi:10.18087/cardio.2495.</mixed-citation><mixed-citation xml:lang="en">Ankudinov AS, Kalyagin AN. Analysis of the relationship of immunological factors and inflammatory markers with the course of chronic heart failure on the background of rheumatoid arthritis. Kardiologiia. 2018;58(10S):4-8. (In Russ.) doi:10.18087/cardio.2495.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis and Cartilage. 2014;22(3):363-88. doi:10.1016/j.joca.2014.01.003.</mixed-citation><mixed-citation xml:lang="en">McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis and Cartilage. 2014;22(3):363-88. doi:10.1016/j.joca.2014.01.003.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Brine LR. The Diabetic Heart Failure With Preserved Ejection Fraction Phenotype Is it Real and Is It Worth Targeting Therapeutically? Circulation. 2017;135(8):736-40. doi:10.1161/CIRCULATIONAHA.116.025957.</mixed-citation><mixed-citation xml:lang="en">Brine LR. The Diabetic Heart Failure With Preserved Ejection Fraction Phenotype Is it Real and Is It Worth Targeting Therapeutically? Circulation. 2017;135(8):736-40. doi:10.1161/CIRCULATIONAHA.116.025957.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Мареев В. Ю., Фомин И.В., Агеев Ф.Т. и др. Клинические рекомендации ОССН — РКО — РНМОТ. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН). Диагностика, профилактика и лечение. Кардиология. 2018;58(6s):8-158. doi:10.18087/cardio.2475.</mixed-citation><mixed-citation xml:lang="en">Mareev VYu, Fomin IV, Ageev FT, et al. Clinical recommendations OSSN — RKO — RNMOT. Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Cardiology. 2018;58(6s):8-158. (In Russ.) doi:10.18087/cardio.2475.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/ European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580-8. doi:10.1136/ard.2010.138461.</mixed-citation><mixed-citation xml:lang="en">Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/ European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580-8. doi:10.1136/ard.2010.138461.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Насонов Е. Л. Ревматология. Клинические рекомендации. М.: ГЭОТАРМедиа, 2017. 464 с. ISBN 978-5-9704-4261-6.</mixed-citation><mixed-citation xml:lang="en">Nasonov EL. Rheumatology. Clinical recommendations. M.: GEOTAR-Media, 2017. р. 464. (In Russ.) ISBN 978-5-9704-4261-6.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA. М.: МедиаСфера, 2002. 312 с. ISBN 5-89084- 013-4.</mixed-citation><mixed-citation xml:lang="en">Rebrova OYu. Statistical analysis of medical data. Application of the STATISTICA application package. М.: MediaSfera, 2002. р. 312. (In Russ.) ISBN 5-89084- 013-4.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Prasad M, Hermann J, Sherine E, et al. Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Nar Rev Cardiol. 2015;12(3):168-76. doi:10.1038/nrcardio.2014.206</mixed-citation><mixed-citation xml:lang="en">Prasad M, Hermann J, Sherine E, et al. Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Nar Rev Cardiol. 2015;12(3):168-76. doi:10.1038/nrcardio.2014.206</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Nurmohamed MT, Heslinga M, Kitas GD. Cardiovascular comorbidity in rheumatic disease. Nat Rev Rheumatol. 2015;11:693-704. doi:10.1038/nrrheum.2015.112.</mixed-citation><mixed-citation xml:lang="en">Nurmohamed MT, Heslinga M, Kitas GD. Cardiovascular comorbidity in rheumatic disease. Nat Rev Rheumatol. 2015;11:693-704. doi:10.1038/nrrheum.2015.112.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Garrido-Urbani S, Meguenani M, Montecucco F, Imhof BA. Immunological aspects of atherosclerosis. Semin Immunopathol. 2014;36(1):73-91. doi:10.1007/s00281-013-0402-8.</mixed-citation><mixed-citation xml:lang="en">Garrido-Urbani S, Meguenani M, Montecucco F, Imhof BA. Immunological aspects of atherosclerosis. Semin Immunopathol. 2014;36(1):73-91. doi:10.1007/s00281-013-0402-8.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Skeoch S, Bruce IN. Atherosclerosis in rheumatoid arthritis: is it all about inflammation? Nat Rev Rheumatol. 2015;11:390-400. doi:10.1038/nrrheum.2015.40.</mixed-citation><mixed-citation xml:lang="en">Skeoch S, Bruce IN. Atherosclerosis in rheumatoid arthritis: is it all about inflammation? Nat Rev Rheumatol. 2015;11:390-400. doi:10.1038/nrrheum.2015.40.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Mitchell C, Rahko PS, Blauwet LA, et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American society of echocardiography. J Am Soc Echocardiograph. 2019;32(1):1-64. doi:10.1016/j.echo.2018.06.004.</mixed-citation><mixed-citation xml:lang="en">Mitchell C, Rahko PS, Blauwet LA, et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American society of echocardiography. J Am Soc Echocardiograph. 2019;32(1):1-64. doi:10.1016/j.echo.2018.06.004.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Perez AV, Doehner W, Haehling S, et al. The relationship between tumor necrosis factor-α, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure. Int J Cardiol. 2010;141(1):39-43. doi:10.1016/j.ijcard.2008.11.146.</mixed-citation><mixed-citation xml:lang="en">Perez AV, Doehner W, Haehling S, et al. The relationship between tumor necrosis factor-α, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure. Int J Cardiol. 2010;141(1):39-43. doi:10.1016/j.ijcard.2008.11.146.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Haviv-Yadid Y, Segal Y, Dagan A, et al. Mortality of patients with rheumatoid arthritis requiring intensive care: a single-center retrospective study. Clin Rheumatol. 2019;38(11):3015-23. doi:10.1007/s10067-019-04651-w.</mixed-citation><mixed-citation xml:lang="en">Haviv-Yadid Y, Segal Y, Dagan A, et al. Mortality of patients with rheumatoid arthritis requiring intensive care: a single-center retrospective study. Clin Rheumatol. 2019;38(11):3015-23. doi:10.1007/s10067-019-04651-w.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
